ArticleApoptosis : an international journal on programmed cell death2026
SIRT1-regulated mitophagy mitigates lipotoxicity-induced ferroptosis in diabetic kidney disease.
Article in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SPARC Drives Podocyte Mitochondrial Damage and Ferroptosis in Diabetic Kidney Disease Following Klotho Deficiency.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Regulated cell death: a multidimensional regulatory network in the pathogenesis of renal fibrosis.Apoptosis : an international journal on programmed cell death · 2026Review
- Tubular injury in diabetic kidney disease: a focus on regulated cell death.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diabetic kidney disease (DKD) is characterized by renal lipid deposition, andlipotoxicity-induced ferroptosis plays a pivotal role in its progression. This study aimed to elucidate the regulatory mechanism of silent information regulator 1 (SIRT1) in lipotoxicity-induced ferroptosis in DKD using clinical samples, animal models, and cellular experiments. Renal tissues from DKD patients and non-diabetic controls were collected for pathological and molecular analyses. DKD mouse model was established by combining a high-fat diet (HFD) with streptozotocin (STZ) injection. Human renal proximal tubular epithelial cells (HK-2) were exposed to palmitic acid/high glucose (PA/HG) to mimic lipotoxic sress. SIRT1 overexpression or knockdown was achieved using lentiviral vectors. Mitophagy was evaluated by Western blot, qPCR, and immunohistochemistry (IHC), and transmission electron microscopy (TEM), focusing on the expression of PINK1, Parkin, LC3B, and P62. Ferroptosis was assessed by detecting the expression of glutathione peroxidase 4 (GPX4), xCT, Ferritin, as well as the levels of malondialdehyde (MDA), and reactive oxygen species (ROS), alongside TEM observations of ferroptotic mitochondrial alterations. The mitophagy inhibitor Mdivi-1 and ferroptosis inhibitor Ferrostatin-1 (Fer-1) were used for mechanistic validation. In renal tubules of DKD patients and HFD/STZ-induced DKD mice, lipid droplet membrane protein (Perilipin-2) expression and lipid deposition were markedly elevated, while SIRT1 expression was significantly reduced and negatively correlated with lipid deposition (P < 0.05). PA/HG treated HK-2 cells reproduced these features. SIRT1 deficiency impaired mitophagy, as evidenced by reduced expression of PINK1, Parkin, and LC3B, increased P62 levels (P < 0.05), and TEM revealed mitochondrial swelling with decreased autophagosomes. Furthermore, SIRT1 knockdown exacerbated ferroptosis, characterized by reduced GPX4, xCT, and Ferritin expression, increased MDA and ROS levels (P < 0.05), and mitochondrial pyknosis with loss of cristae. Conversely, SIRT1 overexpression restored mitophagy activity and alleviated ferroptosis (P < 0.05). The protective effect of SIRT1 overexpression against PA-induced ferroptosis was abolished by Mdivi-1, while Fer-1 partially rescued SIRT1 downregulation-induced renal fibrosis (P < 0.05). SIRT1 attenuates lipotoxicity-induced ferroptosis in renal tubular epithelial cells by promoting mitophagy, thereby mitigating DKD progression. These findings suggest that SIRT1-mediated mitophagy may represent a potential therapeutic target for DKD.
Indexed as
Identifiers
41945160What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.